» Articles » PMID: 27042030

Effectiveness and Safety of Oxycodone/naloxone in the Management of Chronic Pain in Patients with Systemic Sclerosis with Recurrent Digital Ulcers: Two Case Reports

Overview
Publisher Dove Medical Press
Specialty Geriatrics
Date 2016 Apr 5
PMID 27042030
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Digital ulcers (DUs) are a severe and frequent clinical feature of patients with systemic sclerosis (SSc). The presence of DUs may cause severe pain and often lead to impairment of patient's functional activities and health-related quality of life. Moreover, poor patient cooperation during the wound care procedure due to pain may be associated with a negative outcome of DU healing. Therefore, pain management has a key role in patients with SSc. These two case reports describe the effectiveness and safety of oxycodone/naloxone in patients with SSc complicated by painful chronic DUs. Such a therapy has provided pain relief and consequently an increased compliance during redressing wounds.

Citing Articles

Low Temperature Plasma Jet Treatment Promotes Skin Wound Healing by Enhancing Cell Proliferation via the PI3K-AKT and AMPK Pathways.

Zhu Y, Lian X, Li K, Zhang J, Wu W, Zhang X Int Wound J. 2025; 22(2):e70213.

PMID: 39934939 PMC: 11813701. DOI: 10.1111/iwj.70213.


Infections of scleroderma digital ulcers: A single center cohort retrospective study.

Giuggioli D, Magnani L, Spinella A, Bajocchi G, Palermo A, Lumetti F Dermatol Reports. 2022; 13(3):9075.

PMID: 35003566 PMC: 8672119. DOI: 10.4081/dr.2021.9075.


A patient-centered approach to the burden of symptoms in patients with scleroderma treated with Bosentan: A prospective single-center observational study.

Rezus E, Burlui A, Gafton B, Stratulat T, Zota G, Cardoneanu A Exp Ther Med. 2020; 19(3):1739-1746.

PMID: 32104228 PMC: 7027142. DOI: 10.3892/etm.2019.8361.


Review of local wound management for scleroderma-associated digital ulcers.

Lebedoff N, Frech T, Shanmugam V, Fischer A, Erhardt D, Kolfenbach J J Scleroderma Relat Disord. 2020; 3(1):66-70.

PMID: 32099902 PMC: 7041902. DOI: 10.5301/jsrd.5000268.


Evidence-based management of Raynaud's phenomenon.

Herrick A Ther Adv Musculoskelet Dis. 2017; 9(12):317-329.

PMID: 29201156 PMC: 5700788. DOI: 10.1177/1759720X17740074.

References
1.
Mouthon L, Mestre-Stanislas C, Berezne A, Rannou F, Guilpain P, Revel M . Impact of digital ulcers on disability and health-related quality of life in systemic sclerosis. Ann Rheum Dis. 2009; 69(1):214-7. DOI: 10.1136/ard.2008.094193. View

2.
Khanna D, Hays R, Maranian P, Seibold J, Impens A, Mayes M . Reliability and validity of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument. Arthritis Rheum. 2009; 61(9):1257-63. PMC: 2767193. DOI: 10.1002/art.24730. View

3.
Berezne A, Seror R, Morell-Dubois S, de Menthon M, Fois E, Dzeing-Ella A . Impact of systemic sclerosis on occupational and professional activity with attention to patients with digital ulcers. Arthritis Care Res (Hoboken). 2010; 63(2):277-85. DOI: 10.1002/acr.20342. View

4.
Ennis H, Vail A, Wragg E, Taylor A, Moore T, Murray A . A prospective study of systemic sclerosis-related digital ulcers: prevalence, location, and functional impact. Scand J Rheumatol. 2013; 42(6):483-6. DOI: 10.3109/03009742.2013.780095. View

5.
Mouthon L, Carpentier P, Lok C, Clerson P, Gressin V, Hachulla E . Ischemic digital ulcers affect hand disability and pain in systemic sclerosis. J Rheumatol. 2014; 41(7):1317-23. DOI: 10.3899/jrheum.130900. View